Published in FEBS Lett on October 20, 2006
Hyaluronan as an immune regulator in human diseases. Physiol Rev (2011) 2.74
The lymphatic system in health and disease. Lymphat Res Biol (2008) 1.78
ALK1 signaling regulates early postnatal lymphatic vessel development. Blood (2009) 1.76
Immunohistochemical examination on the distribution of cells expressed lymphatic endothelial marker podoplanin and LYVE-1 in the mouse tongue tissue. Acta Histochem Cytochem (2010) 1.01
A role for all-trans-retinoic acid in the early steps of lymphatic vasculature development. J Vasc Res (2010) 0.88
Hyaluronan, Inflammation, and Breast Cancer Progression. Front Immunol (2015) 0.87
CRSBP-1/LYVE-1 ligands disrupt lymphatic intercellular adhesion by inducing tyrosine phosphorylation and internalization of VE-cadherin. J Cell Sci (2011) 0.84
Hyaluronan as a therapeutic target in human diseases. Adv Drug Deliv Rev (2015) 0.81
Aberrant lymphatic endothelial progenitors in lymphatic malformation development. PLoS One (2015) 0.80
Ectodomain Shedding of Lymphatic Vessel Endothelial Hyaluronan Receptor 1 (LYVE-1) Is Induced by Vascular Endothelial Growth Factor A (VEGF-A). J Biol Chem (2016) 0.77
Low-molecular-weight hyaluronan (LMW-HA) accelerates lymph node metastasis of melanoma cells by inducing disruption of lymphatic intercellular adhesion. Oncoimmunology (2016) 0.75
Angiogenesis in health and disease. Nat Med (2003) 14.02
LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol (1999) 7.27
Autocrine growth factors and cancer. Nature (1985) 5.97
Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities. Genes Dev (1994) 5.66
The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinol (1991) 5.61
Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proc Natl Acad Sci U S A (1998) 4.48
Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Nat Med (1999) 4.33
PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis. Cancer Cell (2004) 4.12
Proteolytic processing regulates receptor specificity and activity of VEGF-C. EMBO J (1997) 4.07
Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci U S A (1991) 3.95
Interstitial-lymphatic mechanisms in the control of extracellular fluid volume. Physiol Rev (1993) 3.58
Mouse LYVE-1 is an endocytic receptor for hyaluronan in lymphatic endothelium. J Biol Chem (2001) 3.35
Inhibition of platelet-derived growth factor receptors reduces interstitial hypertension and increases transcapillary transport in tumors. Cancer Res (2001) 2.79
A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J (1996) 1.95
Targeted mutagenesis of the murine transferrin receptor-2 gene produces hemochromatosis. Proc Natl Acad Sci U S A (2002) 1.92
Structure, function, and molecular control of the skin lymphatic system. J Investig Dermatol Symp Proc (2000) 1.81
Compartmentalization of PDGF on extracellular binding sites dependent on exon-6-encoded sequences. J Cell Biol (1992) 1.54
Involvement of platelet-derived growth factor in disease: development of specific antagonists. Adv Cancer Res (2001) 1.41
A novel mechanism regulating growth factor association with the cell surface: identification of a PDGF retention domain. Genes Dev (1991) 1.36
Identification of a cell retention signal in the B-chain of platelet-derived growth factor and in the long splice version of the A-chain. Cell Regul (1991) 1.34
Blockade of platelet-derived growth factor receptor-beta by CDP860, a humanized, PEGylated di-Fab', leads to fluid accumulation and is associated with increased tumor vascularized volume. J Clin Oncol (2004) 1.26
Lymphatic endothelial cells, lymphangiogenesis, and extracellular matrix. Lymphat Res Biol (2006) 1.26
Concentration dependence of interstitial flow buffering by hyaluronan in synovial joints. Microvasc Res (2000) 0.94
Intracellular turnover, novel secretion, and mitogenically active intracellular forms of v-sis gene product in simian sarcoma virus-transformed cells. Implications for intracellular loop autocrine transformation. J Biol Chem (1990) 0.93
A tyrosinated peptide representing the alternatively spliced exon of the platelet-derived growth factor A-chain binds specifically to cultured cells and interferes with binding of several growth factors. J Biol Chem (1992) 0.87
Changes of tissue fluid hyaluronan (hyaluronic acid) in peripheral lymphedema. Lymphology (1998) 0.87
Cell surface retention sequence binding protein-1 interacts with the v-sis gene product and platelet-derived growth factor beta-type receptor in simian sarcoma virus-transformed cells. J Biol Chem (1999) 0.85
Identification, purification, and characterization of cell-surface retention sequence-binding proteins from human SK-Hep cells and bovine liver plasma membranes. J Biol Chem (1995) 0.84
Cloning, expression, characterization, and role in autocrine cell growth of cell surface retention sequence binding protein-1. J Biol Chem (2003) 0.84
Molecular mechanisms of lymphangiogenesis. Cold Spring Harb Symp Quant Biol (2002) 0.81
Intramuscular cavernous hemangioma. Am J Surg (2008) 1.59
Long-term survival after colon cancer surgery: a variation associated with choice of anesthesia. Anesth Analg (2008) 1.49
TGF-beta control of cell proliferation. J Cell Biochem (2005) 1.43
American College of Surgeons International scholarship programs: 40-year history of support for International Surgical Education. J Am Coll Surg (2010) 1.42
Outcome after colectomy for Clostridium difficile colitis. Dis Colon Rectum (2004) 1.31
Inhibitors of clathrin-dependent endocytosis enhance TGFbeta signaling and responses. J Cell Sci (2009) 1.26
Cholesterol suppresses cellular TGF-beta responsiveness: implications in atherogenesis. J Cell Sci (2007) 1.20
Consensus statement from the first international colloquium on basal cell nevus syndrome (BCNS). Am J Med Genet A (2011) 1.14
Follow-up of colorectal cancer patients after resection with curative intent-the GILDA trial. Surg Oncol (2004) 1.14
Morbidity and mortality of gastrectomy for cancer in Department of Veterans Affairs Medical Centers. Surgery (2002) 1.11
Temporal patterns of postoperative complications. Arch Surg (2003) 1.11
Cholecystectomy in patients with prior ventriculoperitoneal shunts. Am J Surg (2011) 1.05
Appendectomy for appendicitis in patients with schizophrenia. Am J Surg (2007) 1.03
Risk factors for adverse outcomes following surgery for small bowel obstruction. Ann Surg (2006) 1.02
Risk factors for adverse outcomes after the surgical treatment of appendicitis in adults. Ann Surg (2003) 1.02
Costs of follow-up after potentially curative treatment for extremity soft-tissue sarcoma. Int J Oncol (2004) 0.97
Surveillance of patients with breast cancer after curative-intent primary treatment: current practice patterns. J Oncol Pract (2011) 0.97
Hemipelvectomy for severe decubitus ulcers in patients with previous spinal cord injury. Am J Surg (2003) 0.97
The preoperative assessment and postoperative surveillance of patients with colon and rectal cancer. Surg Clin North Am (2002) 0.94
Appendectomy for appendicitis in patients with a prior ventriculoperitoneal shunt. J Surg Res (2007) 0.91
Synthetic TGF-beta antagonist accelerates wound healing and reduces scarring. FASEB J (2002) 0.89
Follow-up for patients with colorectal cancer after curative-intent primary treatment. J Clin Oncol (2004) 0.89
Squamous cell carcinoma arising from the pleura after pneumonectomy for squamous cell carcinoma of the lung. Am J Surg (2010) 0.89
A novel TGF-beta antagonist speeds reepithelialization and reduces scarring of partial thickness porcine burns. J Burn Care Res (2009) 0.89
Patterns of disease and surgical treatment among United States veterans more than 50 years of age with ulcerative colitis. Am J Surg (2003) 0.88
Intestinal adenocarcinoma arising in urinary conduits. Oncol Rep (2011) 0.87
Cellular growth inhibition by TGF-beta1 involves IRS proteins. FEBS Lett (2004) 0.87
Identification of insulin receptor substrate proteins as key molecules for the TbetaR-V/LRP-1-mediated growth inhibitory signaling cascade in epithelial and myeloid cells. FASEB J (2004) 0.86
Priming infants to use pattern information in an object individuation task: the role of comparison. Dev Psychol (2011) 0.86
Accessory spleen masquerading as a pancreatic neoplasm. Am J Surg (2009) 0.86
Extremity soft tissue sarcoma patient follow-up: tumor grade and size affect surveillance strategies after potentially curative surgery. Int J Oncol (2003) 0.85
Cloning, expression, characterization, and role in autocrine cell growth of cell surface retention sequence binding protein-1. J Biol Chem (2003) 0.84
CRSBP-1/LYVE-1 ligands disrupt lymphatic intercellular adhesion by inducing tyrosine phosphorylation and internalization of VE-cadherin. J Cell Sci (2011) 0.84
The central role of angiotensin I-converting enzyme in vertebrate pathophysiology. Curr Top Med Chem (2004) 0.84
Evaluation of patients with clinically suspected melanoma recurrence: current practice patterns of plastic surgeons. Int J Oncol (2002) 0.84
The postoperative surveillance of patients with colon cancer and rectal cancer. Am J Surg (2006) 0.83
Breast cancer in patients with schizophrenia. Am J Surg (2013) 0.82
Interventions to support a palliative care approach in patients with chronic obstructive pulmonary disease: an integrative review. Int J Nurs Stud (2012) 0.82
Features of basal cell carcinomas in basal cell nevus syndrome. Am J Med Genet A (2011) 0.82
How surgeon age affects surveillance strategies for extremity soft tissue sarcoma patients after potentially curative treatment. J Surg Res (2002) 0.81
Lack of association of colonic epithelium telomere length and oxidative DNA damage in Type 2 diabetes under good metabolic control. BMC Endocr Disord (2008) 0.81
Anti-tumor immune responses following neoadjuvant immunotherapy with a recombinant adenovirus expressing HSP72 to rodent tumors. Cancer Immunol Immunother (2005) 0.80
Proctectomy for rectal cancer in patients with prior spinal cord injury. Surg Oncol (2008) 0.80
von Voss-Cherstvoy syndrome with transient thrombocytopenia and normal psychomotor development. Am J Med Genet A (2004) 0.80
Gastrointestinal cancer surgery in patients with a prior ventriculoperitoneal shunt: the department of veterans affairs experience. Gastrointest Cancer Res (2012) 0.80
Surgical decision making in upper aerodigestive tract cancer patient follow-up. Int J Oncol (2002) 0.79
Geographic variation in follow-up after rectal cancer surgery. Int J Oncol (2007) 0.79
Cholecystectomy in patients with previous spinal cord injury. Am J Surg (2002) 0.79
Effect of loading force on the dissolution behavior and surface properties of nickel-titanium orthodontic archwires in artificial saliva. Am J Orthod Dentofacial Orthop (2011) 0.79
Identification and characterization of the acidic pH binding sites for growth regulatory ligands of low density lipoprotein receptor-related protein-1. J Biol Chem (2004) 0.78
Ovarian cancer patient surveillance after curative-intent initial treatment. Gynecol Oncol (2011) 0.78
Abdominal wall necrosis after harvest of both internal thoracic and inferior epigastric arteries. Ann Thorac Surg (2011) 0.78
Surgical treatment for prostate cancer in patients with prior spinal cord injury. Ann Surg Oncol (2005) 0.78
Colon and rectal cancer in the elderly. High incidence of asymptomatic disease, less surgical emergencies, and a favorable short-term outcome. Crit Rev Oncol Hematol (2003) 0.78
Adjuvant chemotherapy for breast cancer in patients with schizophrenia. Oncol Lett (2012) 0.78
Intensity of follow-up after breast cancer surgery: low versus high? Ann Surg Oncol (2013) 0.77
Patient surveillance after initial breast cancer therapy: variation by physician specialty. Am J Surg (2013) 0.77
Association of IL-4RA single nucleotide polymorphisms, HLA-DR and HLA-DQ in children with Alternaria-sensitive moderate-severe asthma. Clin Mol Allergy (2010) 0.76
Eloesser procedure for postpneumonectomy bronchopleural fistula. Am J Surg (2004) 0.76
Clonally related methicillin-resistant Staphylococcus aureus isolated from short-finned pilot whales (Globicephala macrorhynchus), human volunteers, and a bayfront cetacean rehabilitation facility. Microb Ecol (2013) 0.76
Pulmonary resection for non-small cell lung cancer in patients with prior spinal cord injury. J Spinal Cord Med (2006) 0.75
Evaluation of patients with clinically detected recurrence of rectal carcinoma: Current practice patterns of colorectal surgeons. Oncol Lett (2010) 0.75
Clinical trials for colonic stents. Lancet (2007) 0.75
Surgery for constipation in patients with prior spinal cord injury: the Department of Veterans Affairs experience. J Spinal Cord Med (2013) 0.75
A collaborative skin cancer educational program for adolescents. Mo Med (2012) 0.75
How initial tumor stage affects rectal cancer patient follow-up. Oncol Rep (2009) 0.75
Project ECHO: an effective means of increasing palliative care capacity. Am J Manag Care (2017) 0.75
Geographic variation in posttreatment surveillance intensity for patients with cutaneous melanoma. Am J Surg (2003) 0.75
Crossed cerebellar hyperperfusion on ictal FDG PET in astrocytoma. J Clin Neurosci (2009) 0.75
Weenthunga--helping future generations to make healthy decisions. Aust Nurs Midwifery J (2015) 0.75
Picture story. Does Dengue virus fuse using beta-barrels? Nat Struct Biol (2002) 0.75
Preoperative workup and postoperative surveillance for patients undergoing pulmonary metastasectomy. Thorac Surg Clin (2006) 0.75
Practice patterns in rectal cancer patient follow-up are unaffected by surgeon age. J Cancer Educ (2008) 0.75
Picture story. Double, double coils or trouble. Nat Struct Biol (2002) 0.75
Optimal Colostomy Placement in Spinal Cord Injury Patients. Am Surg (2016) 0.75
Tumor immunity and prolonged survival following combined adenovirus-HSP72 and CEA-plasmid vaccination. Vaccine (2005) 0.75
Autoamputation in a patient with cryoglobulinemia. J Rheumatol (2004) 0.75